Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2006 | 12-1999 | 12-1998 | |
| Sales | 0 | 0 | 0 | 13,580 | 20,010 |
| Cost of Goods | N/A | N/A | N/A | 13,940 | 20,250 |
| Gross Profit | N/A | N/A | N/A | -360 | -240 |
| Operating Expenses | 10,099 | 0 | 0 | 330 | 620 |
| Operating Income | -10,099 | N/A | N/A | -690 | -860 |
| Other Income | -1,372 | 0 | 0 | -7,660 | -17,390 |
| Pre-tax Income | -11,471 | 0 | 0 | -8,350 | -18,250 |
| Income Tax | 181 | N/A | N/A | -1,200 | 4,170 |
| Net Income Continuous | -11,652 | N/A | N/A | -7,150 | -22,420 |
| Net Income | $-11,652 | $N/A | $N/A | $-7,150 | $-22,420 |
| EPS Basic Total Ops | -6.22 | N/A | N/A | -2.43 | -11.64 |
| EPS Basic Continuous Ops | -6.22 | N/A | N/A | -2.43 | -11.64 |
| EPS Diluted Total Ops | -6.22 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -6.22 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,985 | $N/A | $N/A | $-690 | $-860 |